Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

the Influence of Remote Ischemic Preconditioning on Inflammation During Human Endotoxemia, a Pilot Proof-of-principle Study

NCT02602977 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02602977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02602977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
the Influence of Remote Ischemic Preconditioning on Inflammation During Human Endotoxemia, a Pilot Proof-of-principle Study
Lead sponsor
Radboud University Medical Center
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2015
Completion date
March 31, 2016
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, infection